Drug Use-Results Survey on Picoprep® Combination Powder

The purpose of this survey is to confirm safety and efficacy with patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bowel Cleansing

Sex eligibility

All sexes

Study type

Observational

Primary location

Investigational Site (there may be other sites in this country)

Shibuya City, Tokyo, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

Treatment and study plan

Sodium Picosulfate, Magnesium Oxide and Citric Acid

Drug

Combination powder for oral solution

Other names: Picoprep®

Primary outcomes

Bowel cleansing assessment for colonoscopy

Time frame: 48 hours after drug administration

Assessment of each part of large intestine using a bowel cleanliness rating scale
Bowel cleansing assessment for colorectal surgery

Time frame: 48 hours after drug administration

Assessment of each part of large intestine using a bowel cleanliness rating scale

Sponsors and collaborators

Lead sponsor

Ferring Pharmaceuticals

Industry

Registry information

Important dates

Study start: 2017
Primary completion: 2021
Study completion: 2021
First posted: Aug 15, 2018
Registry last updated: Jan 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed